Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Designing relevant test methods to characterise the disintegration properties of rapidly disintegrating tablets

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: BAIN, Charlotte (AstraZeneca, Pharmaceutical Technology & Development, Macclesfield, United Kingdom)
  • Co-author(s): Charlotte Bain: Pharmaceutical Technology & Development, AstraZeneca, United Kingdom
    Liz Meehan: Pharmaceutical Technology & Development, AstraZeneca, United Kingdom
    Andrew Megarry: Pharmaceutical Technology & Development, AstraZeneca, United Kingdom
  • Abstract:

    Backgrounds

    Limitations exist with standard pharmacopoeial tablet disintegration tests when characterising rapidly disintegrating formulations. Standard tests rely heavily on the user’s judgement and their ability to visually observe the tablet. This can be challenging when faced with mini-tablets, rapidly disintegrating tablets or opaque media..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses